Katie Collins

Co-Founder, VP Business Development at ECM Therapeutics, Inc.

Katie Collins has a diverse work experience in various roles. Katie co-founded and served as the VP of Business Development at ECM Therapeutics, Inc., a regenerative medicine company focused on developing therapeutic products using extracellular matrix technology. Katie also held the position of Executive Director at the National Board of Physicians and Surgeons, where they provided physicians with the option to maintain board certification. Katie worked as a Marketing and Business Development Consultant at Nucleus Biologics. Prior to that, they were the Director of Development at the J. Craig Venter Institute, where they cultivated generosity for medical research programs. Katie also worked at The Scripps Research Institute, where they held different positions including Donor Relations Officer, HRIS Manager, and HR Analyst I-III.

Katie Collins earned their Bachelor of Science degree in Health Policy and Administration from Penn State University, where they attended from 1996 to 2000. Katie later pursued further education in the field of Financial Analysis for Non-Finance Leaders at Duke University - The Fuqua School of Business. However, specific start and end dates for this program are not provided.

Location

Huntersville, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


ECM Therapeutics, Inc.

1 followers

ECM Therapeutics is a regenerative medicine company that develops natural biomaterial to treat disease and injury. The company also develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM). It provides cues for cell attachment, migration, proliferation, and 3-Dspatial organization.ECM Therapeutics'​ patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. It utilizes the body’s own template to restore naturally occurring functional tissue following injury.ECM Therapeutics was founded in 2018 and is based in Warrendale, Pennsylvania, United States.


Employees

1-10

Links